UMMS Affiliation

Gene Therapy Center; Department of Molecular Genetics and Microbiology; Department of Biochemistry and Molecular Pharmacology; Program in Molecular Medicine; Department of Pediatrics; Program in Bioinformatics

Date

3-2011

Document Type

Article

Subjects

Central Nervous System; Dependovirus; Genetic Vectors; MicroRNAs; Transgenes

Disciplines

Genetics and Genomics | Life Sciences | Medicine and Health Sciences | Nervous System Diseases

Abstract

Recombinant adeno-associated viruses (rAAVs) that can cross the blood-brain-barrier and achieve efficient and stable transvascular gene transfer to the central nervous system (CNS) hold significant promise for treating CNS disorders. However, following intravascular delivery, these vectors also target liver, heart, skeletal muscle, and other tissues, which may cause untoward effects. To circumvent this, we used tissue-specific, endogenous microRNAs (miRNAs) to repress rAAV expression outside the CNS, by engineering perfectly complementary miRNA-binding sites into the rAAV9 genome. This approach allowed simultaneous multi-tissue regulation and CNS-directed stable transgene expression without detectably perturbing the endogenous miRNA pathway. Regulation of rAAV expression by miRNA was primarily via site-specific cleavage of the transgene mRNA, generating specific 5' and 3' mRNA fragments. Our findings promise to facilitate the development of miRNA-regulated rAAV for CNS-targeted gene delivery and other applications.

Rights and Permissions

Citation: Mol Ther. 2011 Mar;19(3):526-35. Epub 2010 Dec 21. Link to article on publisher's website

DOI of Published Version

10.1038/mt.2010.279

Comments

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/

Co-author Seemin Seher Ahmed is a doctoral student in the Interdisciplinary Graduate Program in the Graduate School of Biomedical Sciences (GSBS) at UMass Medical School.

Related Resources

Link to article in PubMed

Journal Title

Molecular Therapy

PubMed ID

21179009

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.